Kiwetinohk Energy Corp. (TSX: KEC) ("Kiwetinohk" or the "Company") and Cygnet Energy Ltd. ("Cygnet" or the "Purchaser"), a ...
Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback